dc.contributor.advisor	Magidson, Jessica
dc.contributor.advisor	Seitz-Brown, CJ
dc.contributor.advisor	Dougherty, Lea
dc.contributor.author	Kleinman, Mary
dc.date.accessioned	2021-01-15T20:04:12Z
dc.date.available	2021-01-15T20:04:12Z
dc.date.issued	2020-11
dc.description.abstract	Background/Objectives: Successful engagement with and retention in medication treatment for opioid use disorder (MOUD) is an important focus in the fight against the opioid crisis. Gaps in opioid use disorder (OUD) care point to a need for improved understanding of factors that affect MOUD outcomes and how barriers may act as syndemic factors, compounding one another’s effects. This study used qualitative methods to solicit feedback about barriers to retention and successful treatment outcomes in methadone maintenance treatment (MMT) and used these findings to build a conceptual framework of interaction. Methods: This study was conducted at a community-based drug treatment center that serves a low-income population, the majority of whom identify as Black or African American. We recruited patients and staff as well as peer recovery coaches who work in OUD recovery across Baltimore City. Semi-structured interviews and focus groups asked about factors that influence MMT treatment outcomes and how barriers co-occur and interact. We used thematic analysis to examine themes pertaining to our research questions and two independent coders coded each transcript based on identified themes. Results: Patient participants (n=20) had a mean age of 48.4 (SD=10.0), 70% male, and 60% Black or African American. Mean reported age of first drug use was 17.7 (SD=5.1). Staff and peer recovery coach (PRC) participants (n=12) had a mean age of 49.2 (SD= 0.7), were 42% male, 75% Black or African American, with an average of 9.6 years working in substance use (SU) treatment. Barriers described by participants fit into several broad themes: individual/self, social, institutional or structural, community or environmental, and stigma. Participants described co-occurrence of these barriers as fueling one another and having a disastrous effect on treatment outcomes. Conclusions: Understanding barriers to successful MOUD (specifically MMT) outcomes experienced by this vulnerable population and considering the synergistic effect of these barriers may assist with identification and promotion of the types of interventions needed to effectively and efficiently mitigate their impact. The conceptual model developed in the analysis of qualitative results for this study can inform future research, including quantitative analysis to build further support for the syndemic relationships presented in the model.	en_US
dc.description.sponsorship	This research was supported by a University of Maryland Dean’s Research Initiative grant awarded to Mary Kleinman. The parent award for this study was funded through an NIH HEAL Initiative grant (R61AT010799; PI: Magidson).	en_US
dc.identifier	https://doi.org/10.13016/pq81-r5fu
dc.identifier.uri	http://hdl.handle.net/1903/26690
dc.relation.isAvailableAt	College of Behavioral & Social Sciences	en_us
dc.relation.isAvailableAt	Psychology	en_us
dc.relation.isAvailableAt	Digital Repository at the University of Maryland	en_us
dc.relation.isAvailableAt	University of Maryland (College Park, MD)	en_us
dc.subject	syndemics	en_US
dc.subject	methadone	en_US
dc.subject	opioid use disorder	en_US
dc.subject	treatment outcomes	en_US
dc.subject	social determinants of health	en_US
dc.title	Psychosocial Syndemics Affecting Treatment Outcomes for Individuals Receiving Medication for Opioid Use Disorder	en_US
dc.type	Thesis	en_US

Psychosocial Syndemics Affecting Treatment Outcomes for Individuals Receiving Medication for Opioid Use Disorder

Files

Original bundle

License bundle

Collections